Acharya Shri Nanesh Hospital

Details
Medical Suppliers In Maharashtra

Name :

Acharya Shri Nanesh Hospital

Address  :

Plot No. 34 to 37,
Sector-8A,
Artist Village,
C.B.D. Belapur

Town  :

Navi Mumbai

State  :

Maharashtra

Country  :

INDIA

Post Code:

400614

Phone  :

022-2757 7790

Web URL  :

Available

Email  :

naneshhospital@gmail.com
Acharya Shri Nanesh Hospital
Specialization
  • Dentistry
  • General Medicine
  • General Surgeon
  • Gynaecology
  • Ophthalmology
  • Orthopedics
  • Pathology Lab
  • Physiotherapy
Facilities

Total Number Of Beds : 42

Advance Facility

  • Medicine Facility
  • Medical Stores
Description
ACHARYASHRI NANESH HOSPITAL is a new Charitable hospital in CBD Belapur Navi MumbaiIt is an Ultramodern fully equipped hospital having 42 Beds It is a part of HS Ranka Foundation which is a registered Charitable Trust involved in a lot of philanthropic activities in the field of Education and Healthcare This is a charitable hospital and is catering to the needs of all sections of society by giving them Grade A facilities at a very affordable cost

History
ACHARYASHRI NANESH HOSPITAL is a new Charitable hospital in CBD Belapur Navi MumbaiIt is an Ultramodern fully equipped hospital having 42 Beds It is a part of HS Ranka Foundation which is a registered Charitable Trust involved in a lot of philanthropic activities in the field of Education and Healthcare This is a charitable hospital and is catering to the needs of all sections of society by giving them Grade A facilities at a very affordable cost
NEWS
German clinical lab to upgrade Indian hospitals

A clinical laboratory in Germany has set to work on improving around 25 hospital laboratories in India setting up over 1000 collection centres as well as a logistics network that will get samples to the labs Medizinisch Diagnostiche Institute Berlin is the largest clinical laboratory in Germany and will be undergoing a significant project in Ind... Read More

ARTICLES
Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More